Analysts expect U.S. Physical Therapy, Inc. (NYSE:USPH) to post $116.02 million in sales for the current fiscal quarter, according to Zacks Investment Research. Two analysts have provided estimates for U.S. Physical Therapy’s earnings. The lowest sales estimate is $115.61 million and the highest is $116.43 million. U.S. Physical Therapy posted sales of $109.20 million in the same quarter last year, which suggests a positive year-over-year growth rate of 6.2%. The firm is expected to report its next quarterly earnings results on Thursday, March 14th.

On average, analysts expect that U.S. Physical Therapy will report full-year sales of $452.58 million for the current financial year, with estimates ranging from $452.17 million to $452.99 million. For the next financial year, analysts anticipate that the firm will report sales of $478.29 million, with estimates ranging from $470.19 million to $486.39 million. Zacks Investment Research’s sales averages are a mean average based on a survey of research firms that that provide coverage for U.S. Physical Therapy.

U.S. Physical Therapy (NYSE:USPH) last posted its quarterly earnings results on Thursday, November 1st. The company reported $0.64 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.58 by $0.06. U.S. Physical Therapy had a net margin of 5.58% and a return on equity of 17.64%. The business had revenue of $113.10 million during the quarter, compared to analyst estimates of $112.79 million. U.S. Physical Therapy’s revenue was up 9.8% on a year-over-year basis.

Several analysts have issued reports on the stock. TheStreet lowered shares of U.S. Physical Therapy from a “b” rating to a “c+” rating in a research report on Friday, November 2nd. Cantor Fitzgerald upped their price target on shares of U.S. Physical Therapy from $103.00 to $107.00 and gave the company a “neutral” rating in a research report on Friday, November 2nd. Four analysts have rated the stock with a hold rating, one has issued a buy rating and one has given a strong buy rating to the stock. The stock presently has an average rating of “Buy” and an average target price of $113.67.

In other news, Director Regg E. Swanson bought 500 shares of the company’s stock in a transaction dated Wednesday, December 26th. The stock was bought at an average cost of $101.17 per share, for a total transaction of $50,585.00. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Lawrance W. Mcafee sold 3,100 shares of the stock in a transaction dated Friday, November 2nd. The stock was sold at an average price of $113.29, for a total transaction of $351,199.00. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 5,600 shares of company stock valued at $637,949. 2.50% of the stock is currently owned by company insiders.

A number of hedge funds have recently added to or reduced their stakes in the stock. Vanguard Group Inc raised its stake in U.S. Physical Therapy by 5.9% in the third quarter. Vanguard Group Inc now owns 767,401 shares of the company’s stock worth $91,014,000 after buying an additional 43,050 shares in the last quarter. Vanguard Group Inc. raised its stake in U.S. Physical Therapy by 5.9% in the third quarter. Vanguard Group Inc. now owns 767,401 shares of the company’s stock worth $91,014,000 after buying an additional 43,050 shares in the last quarter. Morgan Stanley raised its stake in U.S. Physical Therapy by 80.4% in the third quarter. Morgan Stanley now owns 96,651 shares of the company’s stock worth $11,463,000 after buying an additional 43,074 shares in the last quarter. Legal & General Group Plc raised its stake in U.S. Physical Therapy by 7.8% in the third quarter. Legal & General Group Plc now owns 27,073 shares of the company’s stock worth $3,204,000 after buying an additional 1,949 shares in the last quarter. Finally, Teachers Advisors LLC raised its stake in U.S. Physical Therapy by 1.7% in the third quarter. Teachers Advisors LLC now owns 27,717 shares of the company’s stock worth $3,287,000 after buying an additional 469 shares in the last quarter. 99.53% of the stock is owned by institutional investors.

NYSE USPH traded down $0.61 during trading on Friday, hitting $106.73. 57,900 shares of the company’s stock traded hands, compared to its average volume of 97,675. The company has a quick ratio of 1.93, a current ratio of 1.93 and a debt-to-equity ratio of 0.26. U.S. Physical Therapy has a 12-month low of $71.70 and a 12-month high of $129.65. The firm has a market cap of $1.37 billion, a price-to-earnings ratio of 51.31, a PEG ratio of 3.47 and a beta of 1.28.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Read More: How Important is Technical Analysis of Stocks

Get a free copy of the Zacks research report on U.S. Physical Therapy (USPH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.